CCL2 and metabolic syndrome: The up-regulation of osteopontin, monocyte chemoattractant protein–1 (MCP-1), and cyclooxygenase-2 (COX-2) mRNAs in the MetS group was blocked by HK L-137 at either dose (Fig. 3C–E).